BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18797196)

  • 21. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
    Cassano WF; Graham-Pole J; Dickson N
    Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
    Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
    Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
    Zak D; Styler MJ; Rosenbluth JZ; Brodsky I
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):297-9; discussion 300-2. PubMed ID: 16167002
    [No Abstract]   [Full Text] [Related]  

  • 24. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.
    Briccoli A; Rocca M; Salone M; Guzzardella GA; Balladelli A; Bacci G
    Surg Oncol; 2010 Dec; 19(4):193-9. PubMed ID: 19515554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [SURGICAL TREATMENT OF PATIENTS FOR METACHRONOUS METASTASES OF PULMONARY OSTEOSARCOMA. CLINICAL PROGNOSTIC FACTORS].
    Kovalchuk PA; Dedkov AG; Bororov LV; Maksymenko BV
    Klin Khir; 2017; (3):24-6. PubMed ID: 30273472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant adriamycin and cisplatin in newly diagnosed, nonmetastatic osteosarcoma of the extremity.
    Ettinger LJ; Douglass HO; Mindell ER; Sinks LF; Tebbi CK; Risseeuw D; Freeman AI
    J Clin Oncol; 1986 Mar; 4(3):353-62. PubMed ID: 3512785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic osteosarcoma.
    Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
    Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excision of pulmonary metastases of osteogenic sarcoma of the limbs.
    Antunes M; Bernardo J; Salete M; Prieto D; Eugénio L; Tavares P
    Eur J Cardiothorac Surg; 1999 May; 15(5):592-6. PubMed ID: 10386402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary resection for metastatic osteosarcomas: a retrospective analysis of 21 patients.
    Pfannschmidt J; Klode J; Muley T; Hoffmann H; Dienemann H
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):120-3. PubMed ID: 16541354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases?
    Karplus G; McCarville MB; Smeltzer MP; Spyridis G; Rao BN; Davidoff A; Li CS; Shochat S
    J Pediatr Surg; 2009 Apr; 44(4):665-71. PubMed ID: 19361624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
    J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery].
    Farfalli GL; Albergo JI; Lobos PA; Smith DE; Streitenberger PD; Pallotta Rodríguez MG; Aponte-Tinao LA
    Medicina (B Aires); 2015; 75(2):87-90. PubMed ID: 25919869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma.
    Skinner KA; Eilber FR; Holmes EC; Eckardt J; Rosen G
    Arch Surg; 1992 Sep; 127(9):1065-70; discussion 1070-1. PubMed ID: 1514908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
    Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
    Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
    Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.